How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

We're celebrating 25 years of work to advance a bold vision for a just and inclusive democracy and economy that reflects a growing and diversifying nation. Read Taifa Smith Butler's reflection on ...